Belgium has stopped the rollout of the Moderna Covid-19 vaccine to Belgians 30-years-old and younger due to the risk of heart inflammation.
Instead, the country began recommending the Pfizer vaccine for initial vaccination despite also being linked to cardiac inflammation.
Following the advice of the country's Superior Health Council, Moderna vaccines were reallocated for booster doses.
Joris Moonens, a spokesman for the country's care and health agency, said the Moderna vaccine "Will be used for the rest of the booster vaccination campaign unless the scientific insights into its use change." Gudrun Briat, a spokeswoman for Belgium's vaccination task force, said the move was based on research showing a higher risk of cardiac inflammation.
One study in Denmark revealed a higher risk of myocarditis - inflammation of the heart muscle - in young men post-vaccination with either the first or second Moderna dose compared to the Pfizer vaccine.
"If there is an alternative vaccine available, it makes more sense not to take any risks," Briat said.
Belgium's decision to stop offering the Moderna vaccine for those under 30 followed several Nordic countries halting the vaccine over concerns regarding heart inflammation.
It's becoming increasingly difficult to discern fact from fiction, and unfortunately the media has a strong bias. They spin stories to make conservatives look bad and will go to great lengths to avoid reporting on the good that comes from conservative policies. There are a few shining lights in the media landscape-brave conservative outlets that report the truth and offer a different perspective. We must support conservative outlets like this one and ensure that our voices are heard.
Tuesday, January 25, 2022
Belgium Drops Moderna Covid-19 Vaccine for Young People Due to Heart Inflammation Risk
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment